Dysregulated IL-17 signaling has been linked to multiple neonatal morbidities—including sepsis, bronchopulmonary dysplasia, patent ductus arteriosus, and necrotizing enterocolitis—highlighting its developmental relevance [13]. This evidence concerns the gene IL17A and Patent ductus arteriosus.